Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000897069-17-000216
Filing Date
2017-04-06
Accepted
2017-04-06 17:07:23
Documents
1
Effectiveness Date
2017-04-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7999
  Complete submission text file 0000897069-17-000216.txt   9030
Mailing Address 1161 YORK AVE, APT #8C NEW YORK NY 10065
Business Address 1161 YORK AVE, APT #8C NEW YORK NY 10065 610 574 8243
Novita Pharmaceuticals, Inc. (Filer) CIK: 0001509360 (see all company filings)

EIN.: 273537104 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-273682 | Film No.: 17746709